Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review

<h3>Introduction</h3><p dir="ltr">Around 5% of the world’s population is expected to have some degree and type of thalassaemia. Beta thalassaemia (BT) occurs due to a deficient production of the beta-globin chain of haemoglobin. Extramedullary haematopoiesis (EMH) is one...

Full description

Saved in:
Bibliographic Details
Main Author: Eihab A. Subahi (12217761) (author)
Other Authors: Fateen Ata (12217764) (author), Hassan Choudry (12217767) (author), Phool Iqbal (12217770) (author), Mousa A. AlHiyari (12217773) (author), Ashraf T. Soliman (12217776) (author), Vincenzo De Sanctis (12217779) (author), Mohamed A. Yassin (8361183) (author)
Published: 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513547424235520
author Eihab A. Subahi (12217761)
author2 Fateen Ata (12217764)
Hassan Choudry (12217767)
Phool Iqbal (12217770)
Mousa A. AlHiyari (12217773)
Ashraf T. Soliman (12217776)
Vincenzo De Sanctis (12217779)
Mohamed A. Yassin (8361183)
author2_role author
author
author
author
author
author
author
author_facet Eihab A. Subahi (12217761)
Fateen Ata (12217764)
Hassan Choudry (12217767)
Phool Iqbal (12217770)
Mousa A. AlHiyari (12217773)
Ashraf T. Soliman (12217776)
Vincenzo De Sanctis (12217779)
Mohamed A. Yassin (8361183)
author_role author
dc.creator.none.fl_str_mv Eihab A. Subahi (12217761)
Fateen Ata (12217764)
Hassan Choudry (12217767)
Phool Iqbal (12217770)
Mousa A. AlHiyari (12217773)
Ashraf T. Soliman (12217776)
Vincenzo De Sanctis (12217779)
Mohamed A. Yassin (8361183)
dc.date.none.fl_str_mv 2022-03-09T03:00:00Z
dc.identifier.none.fl_str_mv 10.1080/07853890.2022.2048065
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Extramedullary_haematopoiesis_in_patients_with_transfusion_dependent_-thalassaemia_TDT_a_systematic_review/29117018
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Thalassaemia
transfusion-dependent thalassaemia
extramedullary haematopoiesis
dc.title.none.fl_str_mv Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Introduction</h3><p dir="ltr">Around 5% of the world’s population is expected to have some degree and type of thalassaemia. Beta thalassaemia (BT) occurs due to a deficient production of the beta-globin chain of haemoglobin. Extramedullary haematopoiesis (EMH) is one of the complications of BT, mainly observed in minor/intermedia subtypes. EMH is the production of blood cells outside the marrow as a compensatory response to longstanding hypoxia. Due to chronic transfusions, it is not expected in patients with beta-thalassaemia major (BTM). However, there are increasingly reported cases of EMH in BTM. The incidence of EMH in BTM is thought to be <1%. We aim to pool the available data and provide cumulative evidence on the occurrence of EMH in BTM patients. </p><h3>Methods</h3><p dir="ltr">This is a systematic review of case reports, series, and retrospective studies that presented data on the occurrence of EMH in BTM patients. Data were recorded and analyzed in Microsoft Excel 2016 and SPSS 26. The protocol has been registered in PROSPERO: CRD42021242943. </p><h3>Results</h3><p dir="ltr">Data from 253 cases of EMH in BTM patients were extracted with a mean age of 35.3 years. Mean haemoglobin at presentation with EMH was 8.2 mg/dL. Lower limb weakness was the most common presenting feature (N = 23) (paraspinal EMH). Magnetic resonance imaging (MRI) was the most widely used diagnostic modality (226). Overall, blood transfusion was the commonest reported treatment (30), followed by radiotherapy (20), surgery (15), hydroxyurea (12), steroids (6), and exchange transfusion (2). An outcome was reported in 20% of patients, all recovered, except one who died as a result of nosocomial infection. </p><h3>Conclusion</h3><p dir="ltr">EMH is rare in BTM and can occur in any organ system with varied clinical features. MRI can effectively diagnose EMH, and conservative management has similar results compared to invasive treatments. Larger studies, focussing on outcomes may enhance guidelines on preventive and therapeutic strategies for managing EMH in BTM.</p><h3>KEY MESSAGES</h3><p dir="ltr">Extramedullary haematopoiesis is a rare complication in beta thalassaemia. Although it is more common in non-transfusion dependent thalassaemia, increasingly reported cases suggest a higher prevalence of EMH in TDT than what is known before. </p><p dir="ltr">There are no clear guidelines on the management of EMH in TDT, with reported patients showing similar outcomes with conservative invasive treatment modalities. </p><p dir="ltr">More extensive and preferably prospectively designed studies are required focussing on the management of EMH and its outcomes in patients with TDT to formulate evidence-based guidelines.</p><h2>Other Information</h2><p dir="ltr">Published in: Annals of Medicine<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1080/07853890.2022.2048065" target="_blank">https://dx.doi.org/10.1080/07853890.2022.2048065</a></p>
eu_rights_str_mv openAccess
id Manara2_98bdbfd5a1400a13bd26b48d41e9853a
identifier_str_mv 10.1080/07853890.2022.2048065
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29117018
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic reviewEihab A. Subahi (12217761)Fateen Ata (12217764)Hassan Choudry (12217767)Phool Iqbal (12217770)Mousa A. AlHiyari (12217773)Ashraf T. Soliman (12217776)Vincenzo De Sanctis (12217779)Mohamed A. Yassin (8361183)Biomedical and clinical sciencesCardiovascular medicine and haematologyClinical sciencesThalassaemiatransfusion-dependent thalassaemiaextramedullary haematopoiesis<h3>Introduction</h3><p dir="ltr">Around 5% of the world’s population is expected to have some degree and type of thalassaemia. Beta thalassaemia (BT) occurs due to a deficient production of the beta-globin chain of haemoglobin. Extramedullary haematopoiesis (EMH) is one of the complications of BT, mainly observed in minor/intermedia subtypes. EMH is the production of blood cells outside the marrow as a compensatory response to longstanding hypoxia. Due to chronic transfusions, it is not expected in patients with beta-thalassaemia major (BTM). However, there are increasingly reported cases of EMH in BTM. The incidence of EMH in BTM is thought to be <1%. We aim to pool the available data and provide cumulative evidence on the occurrence of EMH in BTM patients. </p><h3>Methods</h3><p dir="ltr">This is a systematic review of case reports, series, and retrospective studies that presented data on the occurrence of EMH in BTM patients. Data were recorded and analyzed in Microsoft Excel 2016 and SPSS 26. The protocol has been registered in PROSPERO: CRD42021242943. </p><h3>Results</h3><p dir="ltr">Data from 253 cases of EMH in BTM patients were extracted with a mean age of 35.3 years. Mean haemoglobin at presentation with EMH was 8.2 mg/dL. Lower limb weakness was the most common presenting feature (N = 23) (paraspinal EMH). Magnetic resonance imaging (MRI) was the most widely used diagnostic modality (226). Overall, blood transfusion was the commonest reported treatment (30), followed by radiotherapy (20), surgery (15), hydroxyurea (12), steroids (6), and exchange transfusion (2). An outcome was reported in 20% of patients, all recovered, except one who died as a result of nosocomial infection. </p><h3>Conclusion</h3><p dir="ltr">EMH is rare in BTM and can occur in any organ system with varied clinical features. MRI can effectively diagnose EMH, and conservative management has similar results compared to invasive treatments. Larger studies, focussing on outcomes may enhance guidelines on preventive and therapeutic strategies for managing EMH in BTM.</p><h3>KEY MESSAGES</h3><p dir="ltr">Extramedullary haematopoiesis is a rare complication in beta thalassaemia. Although it is more common in non-transfusion dependent thalassaemia, increasingly reported cases suggest a higher prevalence of EMH in TDT than what is known before. </p><p dir="ltr">There are no clear guidelines on the management of EMH in TDT, with reported patients showing similar outcomes with conservative invasive treatment modalities. </p><p dir="ltr">More extensive and preferably prospectively designed studies are required focussing on the management of EMH and its outcomes in patients with TDT to formulate evidence-based guidelines.</p><h2>Other Information</h2><p dir="ltr">Published in: Annals of Medicine<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1080/07853890.2022.2048065" target="_blank">https://dx.doi.org/10.1080/07853890.2022.2048065</a></p>2022-03-09T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1080/07853890.2022.2048065https://figshare.com/articles/journal_contribution/Extramedullary_haematopoiesis_in_patients_with_transfusion_dependent_-thalassaemia_TDT_a_systematic_review/29117018CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/291170182022-03-09T03:00:00Z
spellingShingle Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
Eihab A. Subahi (12217761)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Thalassaemia
transfusion-dependent thalassaemia
extramedullary haematopoiesis
status_str publishedVersion
title Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
title_full Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
title_fullStr Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
title_full_unstemmed Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
title_short Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
title_sort Extramedullary haematopoiesis in patients with transfusion dependent β-thalassaemia (TDT): a systematic review
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Thalassaemia
transfusion-dependent thalassaemia
extramedullary haematopoiesis